// App-Quantinova.ai

: Selective Inhibition of Rho Kinase 2 Limits No Re-Flow in Rat Hearts Following Ischemia/Reperfusion

Researchers

Presenter

  • Lucie Pearce

Principal Investigators

  • David He

  • Sean M Davidson

  • Derek M Yellon

Medical Centers

  • Cardiovascular Science, The Hatter Cardiovascular Institute, London

  • The Hatter Cardiovascular Institute, London

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Angiology

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Ischemia-reperfusion injury

  • Coronary Artery Disease

  • Calcified vascular disease

Biomarkers

  • N/A

Drug/Treatment

  • Fasudil

  • DMSO

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved